Literature DB >> 3582658

Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene.

V M Kähäri, P Multimäki, E Vuorio.   

Abstract

Fibroblasts cultured from affected and unaffected skin sites of three scleroderma patients were studied for the activation of type I collagen gene expression. Dot blot hybridizations with pro alpha 2(I) collagen specific cDNA probe revealed 2.9-4.8-fold increases in pro alpha 2(I) mRNA levels in the affected fibroblasts over the unaffected control cells. Transcription rate of the pro alpha 2(I) gene in the nuclei isolated from the same cells was 2.0-3.7-fold higher in the scleroderma fibroblasts than in the controls. The results show that scleroderma fibroblasts have undergone activation of collagen gene expression at the transcriptional level, which subsequently results in elevated procollagen mRNA levels, overproduction of collagen, and development of dermal fibrosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582658     DOI: 10.1016/0014-5793(87)80172-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Transcriptional control mechanisms for the expression of type I collagen genes.

Authors:  B de Crombrugghe; T Vuorio; G Karsenty; S Maity; E C Rutheshouser; H Goldberg
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Role of cytokines in controlling connective tissue gene expression.

Authors:  A Hatamochi; K Mori; H Ueki
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Expression of types I, III and IV collagen genes in fibrotic skin and nerve lesions of toxic oil syndrome patients.

Authors:  J J Gomez-Reino; M Sandberg; P E Carreira; E Vuorio
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

4.  Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels.

Authors:  V M Kähäri; Y Q Chen; M W Su; F Ramirez; J Uitto
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 5.  Alterations in the regulation of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma).

Authors:  S A Jimenez; B Saitta
Journal:  Springer Semin Immunopathol       Date:  1999

6.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Authors:  Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 7.  Clinical aspects of systemic sclerosis (scleroderma).

Authors:  R M Silver
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

8.  Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.

Authors:  B Eckes; C Mauch; G Hüppe; T Krieg
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

9.  Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism.

Authors:  Yunliang Chen; Andrew Leask; David J Abraham; Laura Kennedy; Xu Shi-Wen; Christopher P Denton; Carol M Black; Liaquat S Verjee; Mark Eastwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.